Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Conray 60
2. Iotalamate Meglumine
3. Iotalamate, Meglumine
4. Iotalamate, Methylglucamine
5. Iothalamate, Meglumine
6. Iothalamate, Methylglucamine
7. Iothalamic Acid Meglumine
8. Iothalamic Acid Methylglucamine
9. Meglumine Iotalamate
10. Meglumine Iothalamate
11. Meglumine, Iotalamate
12. Meglumine, Iothalamate
13. Meglumine, Iothalamic Acid
14. Methylglucamine Iotalamate
15. Methylglucamine Iothalamate
16. Methylglucamine, Iothalamic Acid
1. 13087-53-1
2. Meglumine Iotalamate
3. Conray
4. Meglumine Iothalamate
5. Iotalamate Meglumine
6. Xuw72gop7w
7. Iothalamate Meglumine [usp]
8. Meglumine Iotalamate Injection
9. 1-deoxy-1-(methylamino)-d-glucitol 3-(acetylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]benzoate
10. 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic Acid;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol
11. 1-deoxy-1-(methylamino)-d-glucitol 5-acetamido-2,4,6-triiodo-n-methylisophthalamate (salt)
12. Iothalamate Meglumine (usp)
13. Conray 60
14. Conray Meglumin
15. Meglumine Conray
16. Methylglucamine Iotalamate
17. Cysto-conray
18. Methylglucamine Iothalamate
19. Cysto-conray Ii
20. 3-acetamido-2,4,6-triiodo-5-(methylcarbamoyl)benzoic Acid;6-(methylamino)hexane-1,2,3,4,5-pentol
21. Benzoic Acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
22. Contrix 28
23. Conray 30
24. Conray 43
25. Meglumine Isothalamate
26. Conray Meglumine 282
27. Iothalamate Methylglucamine
28. Iotalamate De Methylglucamine
29. Iothalamate Methylglucamine Salt
30. Jotalamsaeure Methylglucaminesalz
31. 1-deoxy-1-(methylamino)-d-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate
32. Einecs 235-998-9
33. Conray (tn)
34. Iothalamic Acid N-methylgucamine Salt
35. Iotalamate De Methylglucamine [french]
36. Iotalamic Acid Meglumine
37. Jotalamsaeure Methylglucaminesalz [german]
38. Unii-xuw72gop7w
39. Meglumine Iothalamate [ban]
40. D-glucitol, 1-deoxy-1-(methylamino)-, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate (salt)
41. Meglumine Iotalamate (jp17)
42. Schembl180546
43. Chembl1201125
44. Chebi:31714
45. Dtxsid10926949
46. Iothalamate Meglumine [vandf]
47. Meglumine Iotalamate [mart.]
48. Iotalamate Meglumine [who-dd]
49. Isophthalamic Acid, 5-acetamido-2,4,6-triiodo-n-methyl-, Compd. With 1-deoxy-1-(methylamino)-d-glucitol (1:1)
50. Iothalamate Meglumine [orange Book]
51. Iothalamate Meglumine [usp Impurity]
52. D01999
53. Vascoray Component Iothalamate Meglumine
54. Iothalamate Meglumine Component Of Vascoray
55. Iothalamic Acid N-methylglucamine Salt [mi]
56. Q27294007
57. 5-acetamido-2,4,6-triiodo-n-methylisophthalamic Acid-methylglucamine
58. Benzoic Acid, 3-(acetylamino)-2,4,6-triiodo-5-[(methylamino)carbonyl]-, Compd. With D-glucitol, 1-deoxy-1-(methylamino)- (1:1)
| Molecular Weight | 809.1 g/mol |
|---|---|
| Molecular Formula | C18H26I3N3O9 |
| Hydrogen Bond Donor Count | 9 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 808.8803 g/mol |
| Monoisotopic Mass | 808.8803 g/mol |
| Topological Polar Surface Area | 209 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 555 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 8 | |
|---|---|
| Drug Name | Conray 30 |
| Drug Label | Conray 30 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 30 contains 30% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6 triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 30% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 2 of 8 | |
|---|---|
| Drug Name | Conray 43 |
| Drug Label | Conray 43 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 43 contains 43% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 3 of 8 | |
|---|---|
| Drug Name | Cysto-conray |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | intravesical, ureteral |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 4 of 8 | |
|---|---|
| Drug Name | Cysto-conray ii |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | Intravesical |
| Strength | 17.2% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 5 of 8 | |
|---|---|
| Drug Name | Conray 30 |
| Drug Label | Conray 30 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 30 contains 30% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6 triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 30% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 6 of 8 | |
|---|---|
| Drug Name | Conray 43 |
| Drug Label | Conray 43 is a sterile aqueous solution intended for use as a diagnostic radiopaque medium. Conray 43 contains 43% w/v iothalamate meglumine which is 1-deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophthalamate (salt), and has... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 7 of 8 | |
|---|---|
| Drug Name | Cysto-conray |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | intravesical, ureteral |
| Strength | 43% |
| Market Status | Prescription |
| Company | Mallinckrodt |
| 8 of 8 | |
|---|---|
| Drug Name | Cysto-conray ii |
| Drug Label | Cysto-Conray II is a sterile aqueous solution intended for instillation as a diagnostic radiopaque medium. Cysto-Conray II contains 17.2% w/v iothalamate meglumine which is 1-Deoxy-1-(methylamino)-D-glucitol 5-acetamido-2,4,6-triiodo-N-methylisophtha... |
| Active Ingredient | Iothalamate meglumine |
| Dosage Form | Solution |
| Route | Intravesical |
| Strength | 17.2% |
| Market Status | Prescription |
| Company | Mallinckrodt |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 43%
USFDA APPLICATION NUMBER - 13295
DOSAGE - INJECTABLE;INJECTION - 60%
USFDA APPLICATION NUMBER - 13295
DOSAGE - INJECTABLE;INJECTION - 30%
USFDA APPLICATION NUMBER - 16983
Digital Content
DATA COMPILATION #PharmaFlow
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
